{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:14:30Z","timestamp":1783617270088,"version":"3.55.0"},"reference-count":25,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Therapeutic plasma exchange (TPE) is increasingly used in pediatric neuroimmunological disorders; however, evidence remains limited, particularly for rare neuroinflammatory and infection-triggered encephalopathy syndromes. We aimed to describe the clinical characteristics, treatment patterns, and outcomes of critically ill children who underwent TPE for neuroimmunological disorders in a tertiary pediatric intensive care unit. Methods: This retrospective observational study included consecutive patients younger than 18 years who received TPE for neuroimmunological disorders between September 2020 and December 2025. Demographic characteristics, disease spectrum, TPE indications, treatment details, neuroimaging findings, cerebrospinal fluid (CSF) characteristics, and clinical outcomes were reviewed. Neurological outcome at hospital discharge was assessed using the Pediatric Cerebral Performance Category (PCPC) score. Results: Twenty-two patients were included. The median age was 104 months (IQR, 62.3\u2013151.8), and 50% were female. Guillain\u2013Barr\u00e9 syndrome (GBS) was the most common diagnosis (n = 6), followed by autoimmune encephalitis (n = 6), infection-triggered encephalopathy syndrome (ITES)\/acute necrotizing encephalopathy (ANE) spectrum disorders (n = 4), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) (n = 3), acute disseminated encephalomyelitis (ADEM) (n = 2), and mild encephalitis\/encephalopathy with a reversible splenial lesion (MERS) (n = 1). The median interval from symptom onset to TPE initiation was 9 days (IQR, 6\u201313), and patients underwent a median of 7 TPE sessions (IQR, 5\u201310.5). Nine patients (40.9%) required invasive mechanical ventilation and four (18.1%) required vasoactive support. Favorable neurological outcomes at hospital discharge were observed in 63.6% of patients, whereas 36.4% had unfavorable neurological outcomes. Mortality occurred in 13.6% of patients and was confined to severe encephalopathic syndromes. No major TPE-related complications were observed. Conclusions: TPE was used across a heterogeneous spectrum of pediatric neuroimmunological disorders, including both guideline-supported and non-standard indications. Approximately one-quarter of patients had conditions not specifically addressed in current ASFA recommendations, highlighting the gap between real-world clinical practice and the available evidence base. Multicenter studies are needed to better define the optimal role, timing, and patient selection criteria for TPE in pediatric neuroimmunology.<\/jats:p>","DOI":"10.3390\/children13070908","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:16:44Z","timestamp":1783613804000},"page":"908","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Plasma Exchange in Critically Ill Children with Neuroimmunological Disorders: A Single-Center Cohort Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7532-7724","authenticated-orcid":false,"given":"Ebru G.","family":"Sahin","sequence":"first","affiliation":[{"name":"Department of Pediatric Intensive Care, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3881-6980","authenticated-orcid":false,"given":"Kubra B.","family":"Guvenc","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulcan A.","family":"Yucel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3741-1044","authenticated-orcid":false,"given":"Elif","family":"Yasar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Radiology, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Varol","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Durak","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, University of Health Sciences, Istanbul 34785, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1212\/NXI.0000000000000663","article-title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient","volume":"7","author":"Cellucci","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/dmcn.16067","article-title":"International consensus definitions for infection-triggered encephalopathy syndromes","volume":"67","author":"Sakuma","year":"2025","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","article-title":"Autoimmune encephalitis: Proposed recommendations for symptomatic and long-term management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejpn.2020.10.005","article-title":"E.U. paediatric MOG consortium consensus: Part 5\u2014Treatment of paediatric MOG antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/dmcn.13925","article-title":"Therapeutic plasma exchange in paediatric neurology: A critical review and proposed treatment algorithm","volume":"60","author":"Eyre","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice: Evidence-based approach from the Writing Committee of the American Society for Apheresis: The ninth special issue","volume":"38","author":"Alquist","year":"2023","journal-title":"J. Clin. Apher."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Eichinger, K., Breu, M., Renken, M., Siegert, S., Hilz, E., Glatter, S., Csaicsich, D., Boehm, M., Lechner, C., and Kornek, B. (2025). Complications of Therapeutic Plasma Exchange in Pediatric Neuroimmune Disorders. Children, 12.","DOI":"10.20944\/preprints202509.1494.v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00003246-199605000-00004","article-title":"PRISM III: An updated Pediatric Risk of Mortality score","volume":"24","author":"Pollack","year":"1996","journal-title":"Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","article-title":"PELOD-2: An update of the pediatric logistic organ dysfunction score","volume":"41","author":"Leteurtre","year":"2013","journal-title":"Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/tme.13144","article-title":"Apheresis procedures for the treatment of patients and for the collection of cellular therapy products: A British Society for Haematology guideline","volume":"35","author":"Howell","year":"2025","journal-title":"Transfus. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-3476(05)82544-2","article-title":"Assessing the outcome of pediatric intensive care","volume":"121","author":"Fiser","year":"1992","journal-title":"J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nagase, H., Yamaguchi, H., Tokumoto, S., Ishida, Y., Tomioka, K., Nishiyama, M., Nozu, K., and Maruyama, A. (2023). Timing of therapeutic interventions against infection-triggered encephalopathy syndrome: A scoping review of the pediatric literature. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1150868"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Shukla, P., Mandalla, A., Elrick, M.J., and Venkatesan, A. (2022). Clinical Manifestations and Pathogenesis of Acute Necrotizing Encephalopathy: The Interface Between Systemic Infection and Neurologic Injury. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.628811"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/acn3.51832","article-title":"CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromes","volume":"10","author":"Dale","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_15","unstructured":"Influenza-Associated Acute Necrotizing Encephalopathy (IA-ANE) Working Group, Silverman, A., Walsh, R., Santoro, J.D., Thomas, K., Ballinger, E., Fisher, K.S., Thomas, A.X., Appavu, B., and Kruer, M.C. (2025). Influenza-associated acute necrotizing encephalopathy in US children. JAMA, 334, 692\u2013701."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1067\/mpd.2003.115","article-title":"Long-term outcome in children with Guillain-Barr\u00e9 syndrome","volume":"142","author":"Vajsar","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2007-981686","article-title":"Clinical presentation and course of childhood Guillain-Barr\u00e9 syndrome: A prospective multicentre study","volume":"38","author":"Korinthenberg","year":"2007","journal-title":"Neuropediatrics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/cc10305","article-title":"Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barr\u00e9 syndrome: A randomized study","volume":"15","author":"Abdelkader","year":"2011","journal-title":"Crit. Care"},{"key":"ref_19","first-page":"e1997","article-title":"Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis","volume":"90","author":"Aarsen","year":"2018","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/jnnp-2024-334957","article-title":"Autoimmune encephalitis: Recovery, residual symptoms and predictors of long-term sequelae","volume":"96","author":"Thakolwiboon","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.braindev.2016.01.009","article-title":"Plasma exchange in pediatric anti-NMDAR encephalitis: A systematic review","volume":"38","author":"Suppiej","year":"2016","journal-title":"Brain Dev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Habibi, M.A., Nezhad Shamohammadi, F., Rajaei, T., Namdari, H., Pashaei, M.R., Farajifard, H., and Ahmadpour, S. (2023). Immunopathogenesis of viral infections in neurological autoimmune disease. BMC Neurol., 23.","DOI":"10.1186\/s12883-023-03239-x"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1212\/NXI.0000000000000471","article-title":"Infection-triggered autoimmunity: The case of herpes simplex virus type 1 and anti-NMDAR antibodies","volume":"5","author":"Dale","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/cid\/cir957","article-title":"Detection of human bocavirus in the cerebrospinal fluid of children with encephalitis","volume":"54","author":"Mitui","year":"2012","journal-title":"Clin. Infect. Dis."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/7\/908\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:34:27Z","timestamp":1783614867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/7\/908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["children13070908"],"URL":"https:\/\/doi.org\/10.3390\/children13070908","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}